C013P: Aflibercept Biosimilar
Recombinant protein composed of the binding domains of two human vascular endothelial growth factor (VEGF) receptors fused with the Fc region of human immunoglobulin gamma 1 (IgG1).
Specificity/Sensitivity: The aflibercept biosimilar protein specifically binds to the human VEGF.
Applications: Functional assays, and those assays for studying biological pathways affected by aflibercept.PA006704-PA1487: ANGPTL1 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human, Rat, Mouse;
Isotype: Rabbit IgG.PA005196-PA2075: ANGPTL3 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human, Rat, Mouse;
Isotype: Rabbit IgG.PA005196-ANT-310: ANGPTL3 Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: WB, ELISA;
Reactivity: Human;
Clone: P1D10AT;
Isotype: Mouse IgG1.BP000052-CYT-248: Recombinant Human Angiopoietin Like Protein 3 (ANGPTL3)
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.
Applications: WB, ELISA.APIM050010: AV-951 (TIVOZANIB)
CAS No.: 475108-18-0.
Purity: 99% (HPLC).
QC: LC/MS, 1HNMR.
Solubility: Soluble in DMSO.APIM050010: AV-951 (TIVOZANIB)
CAS No.: 475108-18-0.
Purity: 99% (HPLC).
QC: LC/MS, 1HNMR.
Solubility: Soluble in DMSO.C001: Avastin Biosimilar Stable Cell Line (CHO)
The yield of Avastin biosimilar from the CHO stable cell line was above 1.7 g/L in a 750 liter manufacturing.
C001P: Bevacizumab Biosimilar, Human VEGF Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody generated from the same parent mouse antibody as ranibizumab.
Specificity/Sensitivity: The monoclonal antibody bevacizumab biosimilar specifically binds to the human VEGF-A.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by bevacizumab.C069P: Brolucizumab Biosimilar, VEGF-A Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade brolucizumab biosimilar specifically binds to the human vascular endothelial growth factor A (VEGF-A).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by brolucizumab.